Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015-Intimation to the Shareholders holding shares in Physical Mode for mandatory furnishing of PAN, KYC Details, Bank Account Details, Nomination and other details.
BIOFILCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Biofil Chemicals has notified shareholders holding physical shares about mandatory requirements to update PAN, KYC details, bank account information, contact details, specimen signatures, and nomination preferences with the company's Registrar and Share Transfer Agent (RTA). The filing cites SEBI Master Circular dated February 6, 2026. Physical shareholders with incomplete records will face restrictions - they cannot lodge grievances or avail service requests until KYC is updated. Dividend and other payments for incomplete folios will only be processed through electronic mode from April 1, 2024. Shareholders can submit documents via in-person verification, hard copies (self-attested), or electronic mode with e-sign through RTA Ankit Consultancy Private Limited.
This is a routine SEBI-mandated compliance exercise with no direct impact on company financials or operations. Physical shareholders who fail to update their details risk delays in receiving dividends and limited access to RTA services. For investors, this filing signals the company's efforts to modernize shareholder records and ensure proper electronic payment of future dividends.